A Theory on Site Engagement
myClin Founder and CEO, James Denmark is proud to be the joint author with Eileen Daniel, Endo Pharmaceuticals Senior Director, Development Operations in this article discussing how to use early site interactions to drive engagement and improve study performance.
IT startup helps clinical trial ecosystem communicate
One of the biggest challenges to working remotely is communication. That's particularly true of clinical trials that have become increasingly complex as management of these trials has shifted to contract research organizations and technical providers play a greater role. Trials have also moved further away from the pharmaceutical companies that sponsor them.
Taking the Clinical Trial into the Cloud: Implementing a Web-based Study Community Oriented to the Investigator Site
myClin founder James Denmark presents at the 2011 DIA Annual meeting with Dr. Robert Scott of Amgen Inc, Eileen Daniel of Endo Pharmaceuticals Inc and Joni Bradley of JB Ashtin Group on topics surrounding the use of online communities to move from the investigator meeting and into the trial with the necessary levels of site engagement for success.
myClin offers virtual communities for sponsors, CROs, sites to stay connected during trials
At the investigator meeting prior to the start of a clinical trial, principal investigators and their staffs sit together to hear the sponsor explain the protocol and to ask questions. Everyone socializes over snacks or a meal, connecting faces to names and discussing the ins and outs of the trial.
myClin: Clinical Trial Software Company Expands To New Old City Office
Old City startup myClin wants to make running clinical trials effortless. (We're talking about the studies that researchers conduct to test drugs or medical devices on humans before they go to market.) myClin's software aims to facilitate communication between all the moving parts of a clinical trial.
Webinar: I'm the Millennial That Is Running Your Clinical Trial
This webinar with James Denmark, Founder and CEO at myClin, and John Silowsky, Director of Clinical Operations at Nektar Therapeutics, provides insight into the role of millennials in running clinical trials. It discusses demographic trends and present examples, case studies and recommendations on leveraging private social networking technology to maintain clinical oversight.